ZYUS Life Sciences Corporation
ZLSCF
$0.60
-$0.06-9.09%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 256.10K | 610.80K | 1.89M | 4.43M | 6.74M |
Total Receivables | 299.80K | 800.80K | 582.70K | 474.80K | 385.90K |
Inventory | 1.45M | 1.50M | 1.63M | 1.55M | 2.92M |
Prepaid Expenses | 571.50K | 341.90K | 510.30K | 235.50K | 1.48M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 421.00K | -- |
Total Current Assets | 2.58M | 3.25M | 4.61M | 7.11M | 11.52M |
|
|||||
Total Current Assets | 2.58M | 3.25M | 4.61M | 7.11M | 11.52M |
Net Property, Plant & Equipment | 8.84M | 9.21M | 9.86M | 10.52M | 11.03M |
Long-term Investments | 4.35M | 4.29M | 4.34M | 4.45M | 4.34M |
Goodwill | 4.35M | 4.29M | 4.34M | 4.45M | 4.34M |
Total Other Intangibles | 9.28M | 9.29M | 9.31M | 9.33M | 26.09M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 112.50K | 111.10K | 112.30K | 115.10K | 115.30K |
Total Assets | 25.15M | 26.15M | 28.23M | 31.52M | 53.10M |
|
|||||
Total Accounts Payable | 6.77M | 5.88M | 4.61M | 2.60M | 4.62M |
Total Accrued Expenses | -- | -- | -- | 2.47M | -- |
Short-term Debt | 316.10K | 255.00K | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.50M | 4.87M | 4.85M | 4.96M | 5.55M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 10.58M | 11.01M | 9.46M | 10.03M | 10.17M |
|
|||||
Total Current Liabilities | 10.58M | 11.01M | 9.46M | 10.03M | 10.17M |
Long-Term Debt | 316.80K | 501.20K | 550.20K | 482.30K | 522.60K |
Short-term Debt | 316.10K | 255.00K | -- | -- | -- |
Capital Leases | 1.75M | 1.79M | 1.88M | 1.98M | 1.96M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.49M | 1.50M | 1.51M | 1.53M | 5.90M |
Total Liabilities | 14.13M | 14.80M | 13.40M | 14.02M | 18.55M |
|
|||||
Common Stock & APIC | 120.22M | 116.69M | 117.81M | 120.76M | 116.83M |
Retained Earnings | -112.70M | -108.38M | -105.99M | -106.15M | -85.53M |
Treasury Stock & Other | 3.50M | 3.04M | 3.01M | 2.89M | 3.25M |
Total Common Equity | 11.02M | 11.35M | 14.82M | 17.50M | 34.55M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 11.02M | 11.35M | 14.82M | 17.50M | 34.55M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 11.02M | 11.35M | 14.82M | 17.50M | 34.55M |
|